Down-regulation of A-FABP predicts non-muscle invasive bladder cancer progression: investigation with a long term clinical follow-up
Abstract Background Non-muscle invasive bladder cancers (NMIBC: pTa, pT1) are characterised by a high risk of recurrence and/or progression. Identification of prognostic markers is needed to improve both diagnosis and management of the disease. The aim of this study was to analyse the expression of...
Main Authors: | Christel Mathis, Isabelle Lascombe, Franck Monnien, Hugues Bittard, François Kleinclauss, Isabelle Bedgedjian, Sylvie Fauconnet, Séverine Valmary-Degano |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-018-5137-4 |
Similar Items
-
Evaluation of Urinary L-FABP as a Tubular Damage Marker in Pediatric Neurogenic Bladder—A Pilot Study
by: Joanna Bagińska, et al.
Published: (2024-01-01) -
High expression of FABP4 and FABP6 in patients with colorectal cancer
by: Yaqin Zhang, et al.
Published: (2019-10-01) -
L-FABP and I-FABP expression in newborn rats changes inversely in the model of necrotizing enterocolitis
by: Luís Felipe Tsuyoshi Mitidiero, et al.
Published: (2014-01-01) -
MCF-7 Drug Resistant Cell Lines Switch Their Lipid Metabolism to Triple Negative Breast Cancer Signature
by: Jose Adriá-Cebrián, et al.
Published: (2021-11-01) -
Silencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease
by: Takako Mukai, et al.
Published: (2017-07-01)